ERBB2 and breast cancer: Here, we report the results of in-depth biological, immunological, and functional studies demonstrating that M/D-driven mammary tumors recapitulate several biological and immunological features of human luminal B (highly proliferative HR+HER2−) BC, hence constituting a privileged platform to investigate therapeutic strategies with translational potential.